Windlas Biotech Limited (WINDLAS) — Financial Flexibility Index
Windlas Biotech Limited (WINDLAS) has a Financial Flexibility Index of 0.04x as of September 2023. Free cash flow of Rs66.60 Million (operating CF Rs66.60 Million minus capex Rs0.00) represents 0% of total liabilities (Rs1.54 Billion). Also explore Windlas Biotech Limited equity growth rate to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Windlas Biotech Limited Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Windlas Biotech Limited across 8 annual periods. Check WINDLAS PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Windlas Biotech Limited (2018–2025)
Year-by-year free cash flow to debt coverage for Windlas Biotech Limited. For the full company profile including market capitalisation, see market cap of Windlas Biotech Limited.
| Year | Flexibility Index | Free Cash Flow (INR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.47x | Rs1.20 Billion | Rs681.87 Million | Rs2.55 Billion | ▼ -43.2% |
| 2024 | 0.83x | Rs1.47 Billion | Rs1.09 Billion | Rs1.76 Billion | ▼ -20.1% |
| 2023 | 1.04x | Rs1.32 Billion | Rs609.65 Million | Rs1.27 Billion | ▲ +318.4% |
| 2022 | 0.25x | Rs239.34 Million | Rs91.30 Million | Rs962.33 Million | ▲ +39.4% |
| 2021 | 0.18x | Rs173.01 Million | Rs114.54 Million | Rs970.04 Million | ▼ -43.0% |
| 2020 | 0.31x | Rs403.16 Million | Rs250.06 Million | Rs1.29 Billion | ▲ +18.6% |
| 2019 | 0.26x | Rs276.08 Million | Rs186.54 Million | Rs1.05 Billion | ▼ -21.4% |
| 2018 | 0.34x | Rs553.73 Million | Rs295.91 Million | Rs1.65 Billion | — |